1514 related articles for article (PubMed ID: 16230320)
21. Altered diffusion tensor in multiple sclerosis normal-appearing brain tissue: cortical diffusion changes seem related to clinical deterioration.
Vrenken H; Pouwels PJ; Geurts JJ; Knol DL; Polman CH; Barkhof F; Castelijns JA
J Magn Reson Imaging; 2006 May; 23(5):628-36. PubMed ID: 16565955
[TBL] [Abstract][Full Text] [Related]
22. Investigation of quantitative magnetisation transfer parameters of lesions and normal appearing white matter in multiple sclerosis.
Cercignani M; Basile B; Spanò B; Comanducci G; Fasano F; Caltagirone C; Nocentini U; Bozzali M
NMR Biomed; 2009 Jul; 22(6):646-53. PubMed ID: 19322806
[TBL] [Abstract][Full Text] [Related]
23. Altered glutamate reuptake in relapsing-remitting and secondary progressive multiple sclerosis cortex: correlation with microglia infiltration, demyelination, and neuronal and synaptic damage.
Vercellino M; Merola A; Piacentino C; Votta B; Capello E; Mancardi GL; Mutani R; Giordana MT; Cavalla P
J Neuropathol Exp Neurol; 2007 Aug; 66(8):732-9. PubMed ID: 17882017
[TBL] [Abstract][Full Text] [Related]
24. Atrophy in white matter fiber tracts in multiple sclerosis is not dependent on tract length or local white matter lesions.
Kezele IB; Arnold DL; Collins DL
Mult Scler; 2008 Jul; 14(6):779-85. PubMed ID: 18611990
[TBL] [Abstract][Full Text] [Related]
25. Meningeal inflammation is not associated with cortical demyelination in chronic multiple sclerosis.
Kooi EJ; Geurts JJ; van Horssen J; Bø L; van der Valk P
J Neuropathol Exp Neurol; 2009 Sep; 68(9):1021-8. PubMed ID: 19680141
[TBL] [Abstract][Full Text] [Related]
26. [Pathology and definition of multiple sclerosis].
Dutta R; Trapp BD
Rev Prat; 2006 Jun; 56(12):1293-8. PubMed ID: 16948216
[TBL] [Abstract][Full Text] [Related]
27. Determinants of disability in multiple sclerosis at various disease stages: a multiparametric magnetic resonance study.
Pulizzi A; Rovaris M; Judica E; Sormani MP; Martinelli V; Comi G; Filippi M
Arch Neurol; 2007 Aug; 64(8):1163-8. PubMed ID: 17698707
[TBL] [Abstract][Full Text] [Related]
28. Extent of cerebellum, subcortical and cortical atrophy in patients with MS: a case-control study.
Ramasamy DP; Benedict RH; Cox JL; Fritz D; Abdelrahman N; Hussein S; Minagar A; Dwyer MG; Zivadinov R
J Neurol Sci; 2009 Jul; 282(1-2):47-54. PubMed ID: 19201003
[TBL] [Abstract][Full Text] [Related]
29. Multislice brain myelin water fractions at 3T in multiple sclerosis.
Oh J; Han ET; Lee MC; Nelson SJ; Pelletier D
J Neuroimaging; 2007 Apr; 17(2):156-63. PubMed ID: 17441837
[TBL] [Abstract][Full Text] [Related]
30. Accumulation of cortical lesions in MS: relation with cognitive impairment.
Roosendaal SD; Moraal B; Pouwels PJ; Vrenken H; Castelijns JA; Barkhof F; Geurts JJ
Mult Scler; 2009 Jun; 15(6):708-14. PubMed ID: 19435749
[TBL] [Abstract][Full Text] [Related]
31. The contribution of diffusion-weighted MR imaging in multiple sclerosis during acute attack.
Yurtsever I; Hakyemez B; Taskapilioglu O; Erdogan C; Turan OF; Parlak M
Eur J Radiol; 2008 Mar; 65(3):421-6. PubMed ID: 17587524
[TBL] [Abstract][Full Text] [Related]
32. A new focal EAE model of cortical demyelination: multiple sclerosis-like lesions with rapid resolution of inflammation and extensive remyelination.
Merkler D; Ernsting T; Kerschensteiner M; Brück W; Stadelmann C
Brain; 2006 Aug; 129(Pt 8):1972-83. PubMed ID: 16714315
[TBL] [Abstract][Full Text] [Related]
33. Intra-cortical connectivity in multiple sclerosis: a neurophysiological approach.
Tecchio F; Zito G; Zappasodi F; Dell' Acqua ML; Landi D; Nardo D; Lupoi D; Rossini PM; Filippi MM
Brain; 2008 Jul; 131(Pt 7):1783-92. PubMed ID: 18502782
[TBL] [Abstract][Full Text] [Related]
34. Gray and normal-appearing white matter in multiple sclerosis: an MRI perspective.
Vrenken H; Geurts JJ
Expert Rev Neurother; 2007 Mar; 7(3):271-9. PubMed ID: 17341175
[TBL] [Abstract][Full Text] [Related]
35. Demyelination, inflammation, and neurodegeneration in multiple sclerosis deep gray matter.
Vercellino M; Masera S; Lorenzatti M; Condello C; Merola A; Mattioda A; Tribolo A; Capello E; Mancardi GL; Mutani R; Giordana MT; Cavalla P
J Neuropathol Exp Neurol; 2009 May; 68(5):489-502. PubMed ID: 19525897
[TBL] [Abstract][Full Text] [Related]
36. Pathogenic Mechanisms Associated With Different Clinical Courses of Multiple Sclerosis.
Lassmann H
Front Immunol; 2018; 9():3116. PubMed ID: 30687321
[TBL] [Abstract][Full Text] [Related]
37. T2 MRI texture analysis is a sensitive measure of tissue injury and recovery resulting from acute inflammatory lesions in multiple sclerosis.
Zhang Y; Zhu H; Mitchell JR; Costello F; Metz LM
Neuroimage; 2009 Aug; 47(1):107-11. PubMed ID: 19361563
[TBL] [Abstract][Full Text] [Related]
38. Voxel-wise assessment of progression of regional brain atrophy in relapsing-remitting multiple sclerosis.
Battaglini M; Giorgio A; Stromillo ML; Bartolozzi ML; Guidi L; Federico A; De Stefano N
J Neurol Sci; 2009 Jul; 282(1-2):55-60. PubMed ID: 19286193
[TBL] [Abstract][Full Text] [Related]
39. Concentric sclerosis (Baló): morphometric and in situ hybridization study of lesions in six patients.
Yao DL; Webster HD; Hudson LD; Brenner M; Liu DS; Escobar AI; Komoly S
Ann Neurol; 1994 Jan; 35(1):18-30. PubMed ID: 8285587
[TBL] [Abstract][Full Text] [Related]
40. Diffusely abnormal white matter in chronic multiple sclerosis: imaging and histopathologic analysis.
Seewann A; Vrenken H; van der Valk P; Blezer EL; Knol DL; Castelijns JA; Polman CH; Pouwels PJ; Barkhof F; Geurts JJ
Arch Neurol; 2009 May; 66(5):601-9. PubMed ID: 19433660
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
